Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms

NCT03429075 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03429075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03429075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
January 7, 2019
Completion date
October 17, 2020
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major